Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 21 studies | 28% ± 12% | |
astrocyte | 18 studies | 50% ± 20% | |
adipocyte | 8 studies | 46% ± 12% | |
myofibroblast cell | 6 studies | 40% ± 15% | |
Mueller cell | 6 studies | 62% ± 15% | |
oligodendrocyte precursor cell | 5 studies | 24% ± 6% | |
connective tissue cell | 4 studies | 27% ± 11% | |
pericyte | 3 studies | 28% ± 9% | |
smooth muscle cell | 3 studies | 31% ± 6% | |
adventitial cell | 3 studies | 30% ± 7% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 22% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 99% | 5578.08 | 178 / 180 | 95% | 557.82 | 410 / 430 |
brain | 88% | 3317.28 | 2334 / 2642 | 90% | 119.64 | 637 / 705 |
breast | 95% | 4577.09 | 435 / 459 | 67% | 36.35 | 754 / 1118 |
lung | 100% | 11991.03 | 577 / 578 | 59% | 28.16 | 685 / 1155 |
stomach | 98% | 5898.63 | 353 / 359 | 51% | 34.08 | 147 / 286 |
intestine | 97% | 3574.43 | 938 / 966 | 49% | 27.85 | 260 / 527 |
bladder | 100% | 10118.29 | 21 / 21 | 34% | 15.40 | 170 / 504 |
esophagus | 90% | 2984.15 | 1298 / 1445 | 40% | 17.54 | 74 / 183 |
kidney | 71% | 2181.52 | 63 / 89 | 55% | 73.40 | 496 / 901 |
uterus | 99% | 4901.68 | 168 / 170 | 26% | 18.15 | 120 / 459 |
prostate | 92% | 3516.48 | 225 / 245 | 31% | 8.43 | 154 / 502 |
adrenal gland | 95% | 3329.19 | 246 / 258 | 20% | 15.08 | 47 / 230 |
pancreas | 27% | 351.01 | 87 / 328 | 78% | 56.38 | 138 / 178 |
adipose | 98% | 7083.40 | 1176 / 1204 | 0% | 0 | 0 / 0 |
skin | 67% | 1437.83 | 1213 / 1809 | 21% | 10.58 | 98 / 472 |
blood vessel | 87% | 3251.88 | 1167 / 1335 | 0% | 0 | 0 / 0 |
heart | 75% | 3113.13 | 642 / 861 | 0% | 0 | 0 / 0 |
spleen | 74% | 1972.80 | 178 / 241 | 0% | 0 | 0 / 0 |
thymus | 64% | 1170.46 | 417 / 653 | 9% | 3.71 | 53 / 605 |
liver | 5% | 63.50 | 11 / 226 | 2% | 0.78 | 8 / 406 |
tonsil | 0% | 0 | 0 / 0 | 7% | 2.18 | 3 / 45 |
eye | 0% | 0 | 0 / 0 | 5% | 2.22 | 4 / 80 |
muscle | 3% | 48.74 | 22 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_1902430 | Biological process | negative regulation of amyloid-beta formation |
GO_0016485 | Biological process | protein processing |
GO_0007155 | Biological process | cell adhesion |
GO_1902993 | Biological process | positive regulation of amyloid precursor protein catabolic process |
GO_0010954 | Biological process | positive regulation of protein processing |
GO_0005615 | Cellular component | extracellular space |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0031012 | Cellular component | extracellular matrix |
GO_0005201 | Molecular function | extracellular matrix structural constituent |
GO_0046872 | Molecular function | metal ion binding |
GO_0005515 | Molecular function | protein binding |
GO_0050693 | Molecular function | LBD domain binding |
Gene name | SPON1 |
Protein name | Spondin-1 (F-spondin) (Vascular smooth muscle cell growth-promoting factor) SPON1 protein |
Synonyms | VSGP KIAA0762 |
Description | FUNCTION: Cell adhesion protein that promotes the attachment of spinal cord and sensory neuron cells and the outgrowth of neurites in vitro. May contribute to the growth and guidance of axons in both the spinal cord and the PNS (By similarity). Major factor for vascular smooth muscle cell. . |
Accessions | Q3ZCT3 ENST00000576479.4 Q9HCB6 |